剺@

lʐ^

w

  • 2005N3@w{wEFmȊwȁ@
  • 2007N3@ww@ȍLȊwU‹Ȋwn@Cmے@C
  • 2010N3@@mے@CCmiwpj擾
    m_uyꖌ敪pZN^[[̖זEAbZCnv

E

  • 2007N4?2010N3@{wpU@ʌ
  • 2010N4?2012N3@w@]ȊwZ^[@AcnC}[a`[@
  • 2012N4?2016N9@ʈȑw@w@򗝊w@
  • 2016N10?݁@_E_oZ^[_o@

e[}

  1. ^E^pÑ_@\ɂ‚
  2. PICK1(Protein Interacting with C Kinase 1)ɂ‚
  3. LQƐ_oϐƂ̊֘Aɂ‚

ASĂ邱

  • ҂𔙑RƎuɕfpȋ^YȂ

C_ЁEՁEA邱

DȂ́A

蕨iɈjC|egT_

Ȃ́A

  • ̓̐DHוCX|[cS

CO̎

  • Yagishita S., Murayama M., Ebihara T., Maruyama K., Takashima A.
    Glycogen Synthase Kinase-3-mediated Phosphorylation in the Most C-terminal Region of Protein Interacting with C Kinase 1 (PICK1) Regulates the Binding of PICK1 to Glutamate Receptor Subunit GluA2, J. Biol. Chem. 290(49): 29438-48, Dec. 2015

  • Iwasa K, Yamamoto S, Takahashi M, Suzuki S, Yagishita S., Awaji T, Maruyama K, Yoshikawa K.
    Prostaglandin F2 FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model, Prostaglandins Leukot Essent Fatty Acids. 91(5), 175-182, Nov. 2014

  • Yamamoto S., Gotoh M., Kawamura Y., Yamashina K., Yagishita S., Awaji T., Tanaka M., Maruyama K., Murakami-Murofushi K., Yoshikawa K.
    Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice, Eur. J. Pharmacol., 741C, 17-24, Jul. 2014

  • Watahiki H., Yagishita S., Futai E., Ishiura S.
    CTF1-51, a truncated carboxyl-terminal fragment of amyloid precursor protein, suppresses the effects of A42-lowering -secretase modulators, Neurosci. Lett. 526, 96-9, 2012

  • Sato K, Tanabe C., Yonemura Y., Watahiki H., Zhao Y., Yagishita S., Ebina M., Suo S., Futai E., Murata M., Ishiura S.
    Localization of mature neprilysin in lipid rafts, J. Neurosci. Res. 90, 870-7, 2012

  • Yonemura Y., Futai E., Yagishita S., Suo S., Tomita T., Iwatsubo T., Ishiura S.
    Comparison of Presenilin 1 and Presenilin 2 -Secretase Activities Using a Yeast Reconstitution System, J. Biol. Chem. 286, 44569-75, 2011

  • Asai, M., Yagishita, S., Iwata N., Saido TC., Ishiura S., Maruyama K.
    An alternative metabolic pathway of amyloid precursor protein C-terminal fragments via cathepsin B in a human neuroglioma model, FASEB J. 25, 3720-30, 2011

  • Yamakawa H., Yagishita S., Futai E., Ishiura S.
    b-Secretase inhibitor potency is decreased by aberrant -cleavage location of "Swedish mutant" amyloid precursor protein, J. Biol. Chem. 285, 1634-42, 2010

  • Futai E., Yagishita S., Ishiura S.
    Nicastrin is dispensable for g-secretase protease activity in the presence of specific presenilin mutations, J. Biol. Chem. 284, 13013-22, 2009

  • Yagishita S., Futai E., Ishiura S.
    In vitro reconstitution of -secretase activity using yeast microsomes, Biochem. Biophys. Res. Commun. 377, 141-145, 2008

  • Osawa S., Funamoto S., Nobuhara M., Wada-Kakuda S., Shimojo M., Yagishita S., Ihara Y.
    Phosphoinositides suppress -secretase in both the detergent-soluble and insoluble states, J. Biol. Chem. 283, 19283-92, 2008

  • Yagishita S., Morishima-Kawashima M., Ishiura S., Ihara Y.
    A46 Is Processed to A40 and A43, but Not to A42, in the Low Density Membrane Domains, J. Biol. Chem. 283, 733-738, 2008

  • Kakuda N., Funamoto S., Yagishita S., Takami M., Osawa S., Dohmae N., Ihara Y.
    Equimolar Production of Amyloid -Protein and APP Intracellular Domain from -Carboxyl Terminal Fragment by -Secretase, J. Biol. Chem. 281, 14776-14786, 2006

  • Yagishita S., Morishima-Kawashima M., Tanimura Y., Ishiura S., Ihara Y.
    DAPT-Induced Intracellular Accumulations of Longer Amyloid -Proteins: Further Implications for the Mechanism of Intramembrane Cleavage by -Secretase, Biochemistry 45, 3952-3960, 2006